Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Shares Outstanding (Weighted Average) (2024 - 2025)

Historic Shares Outstanding (Weighted Average) for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $17.2 million.

  • Kairos Pharma's Shares Outstanding (Weighted Average) rose 6296.13% to $17.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $17.2 million, marking a year-over-year increase of 6296.13%. This contributed to the annual value of $11.4 million for FY2024, which is N/A changed from last year.
  • As of Q2 2025, Kairos Pharma's Shares Outstanding (Weighted Average) stood at $17.2 million, which was up 6296.13% from $15.9 million recorded in Q1 2025.
  • In the past 5 years, Kairos Pharma's Shares Outstanding (Weighted Average) ranged from a high of $17.2 million in Q2 2025 and a low of $10.6 million during Q1 2024